Treatment Rates and Compliance to Treatment in Patients With Familial Hypercholesterolemia

NCT04494464 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 367

Last updated 2020-07-31

No results posted yet for this study

Summary

Familial hypercholesterolemia is a genetic disease characterized by increased levels of low density lipoprotein cholesterol (LDL-C). It is underdiagnosed and undertreated despite relatively high prevalence and significant association with increased mortality.

Conditions

  • Familial Hypercholesterolemia

Interventions

OTHER

No intervention

Sponsors & Collaborators

  • Ankara Yildirim Beyazıt University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-05-31
Completion
2017-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04494464 on ClinicalTrials.gov